Biotech pharma

SynsoryBio

Website
Founded 2023Origin source ↗Checked 2026-09-15

Overview

SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.

Company description As recorded 2026-11-08

Founders & team

Elliot Tague

Founder

I am a PhD and inventor in the fields of synthetic biology and protein engineering. I got my PhD from Boston University, spent time as a visiting graduate student in George Church's lab at Harvard, and worked in various biotech startups

Founder profile As recorded 2026-09-15

Nathan Tague

Founder

I’m a co-founder of SynsoryBio, where we are creating therapeutics that sense-and-respond to disease. I have a background in synthetic biology and protein engineering with a PhD in Biomedical Engineering.

Founder profile As recorded 2026-09-15
2team members reported
Source-reported As recorded 2026-09-15

Founded 2023 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite unreachable
Last website check2026-11-11
Location · source statedBoston, MA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The latest website check does not confirm this company’s website.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationdescriptive evidenceclassified market and modelsourced peoplesourced founding year